CareDx, Inc. (CDNA) earnings date, results and what the price requires
Nasdaq · SEC CIK 0001217234 · SEC filings checked Oct 17, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 30, 2026 | $131.9M | $110.6M | $2.07 | Filing |
| Mar 31, 2026 | Apr 16, 2026 | $117.7M | $2.8M | $0.05 | Filing |
| Dec 31, 2025 | Jan 12, 2026 | $108.4M | $-4.1M | $-0.08 | Filing |
| Sep 30, 2025 | Nov 4, 2025 | $100.1M | $1.7M | $0.03 | Filing |
| Jun 30, 2025 | Aug 6, 2025 | $86.7M | $-8.6M | $-0.16 | Filing |
| Mar 31, 2025 | Apr 30, 2025 | $84.7M | $-10.4M | $-0.19 | Filing |
| Dec 31, 2024 | Jan 13, 2025 | $86.6M | $87.7M | $1.60 | Filing |
| Sep 30, 2024 | Oct 15, 2024 | $82.9M | $-10.6M | $-0.20 | Filing |
What would CareDx, Inc. have to report for its valuation to change?
At $64.00, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about 21.5% a year, to $5.47. On that path the next quarter needs diluted EPS near $0.04, against $0.03 in the quarter ended Sep 30, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | 21.5% | 21.5% |
| EPS needed in final year | $5.47 | $5.47 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. CDNA goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.